Age-related macular degeneration (AMD) is the leading cause of blindness in the West. Delays in injections can cause ...

Current treatments for corneal neovascularization rely on invasive intravitreal injections, which limit patient compliance ...

General practitioners must screen for ocular mpox and refer to ophthalmology urgently to prevent severe vision-threatening ...

Executives from 4D Molecular Therapeutics (NASDAQ:FDMT) outlined the company’s gene therapy platform, clinical progress, and ...

Many dog owners initially notice only small things: The dog squints one eye, rubs its face more often, or the eye appears red ...

The introduction of the first disease-modifying therapies fundamentally transformed the management of geographic atrophy and ...

Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug ...

Women over 50 face increased eye health risks post-menopause due to hormonal shifts. Conditions like dry eye, cataracts, ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at pharmaceuticals stocks, starting with ...

OCGN's gene-agnostic eye therapy aims to treat multiple retinal mutations, with key filings and pivotal data in 2026???2027 set to test its broad platform.

Rates of newborn vitamin K shot refusal remain low but appear to be increasing, raising concerns about misinformation and the need for stronger prenatal counseling.

World Optometry Day aims to celebrate optometry’s contribution to global health and its ongoing efforts to improve access to ...